Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TCT 2025

First-in-Human Study of a Novel IVL-Based Coronary Crossing Device for Calcified Lesions (Shockwave)

Presenter: James C. Spratt

October 27, 2025

Presentation TCT 2025

TCT 165: To evaluate the impact of dose dependency on calcium fractures from the shockwave balloon in calcified lesions

Presenter: Sandeep Basavarajaiah

October 26, 2025

Presentation TCT 2025

You Asked; We Delivered: Introducing Shockwave IVL’s C2 Aero Coronary Catheter - C2+ vs. Aero C2

Presenter: Ziad A. Ali

October 26, 2025

Presentation TCT 2025

You Asked; We Delivered: Introducing Shockwave IVL’s C2 Aero Coronary Catheter - C2 Aero "Case in a Box"

Presenter: Rhian E. Davies

October 26, 2025

Presentation TCT 2025

Delivering with Clinical Data: Shockwave IVL’s Proven Crack Record

Presenter: Yousif Ahmad

October 26, 2025

Presentation TCT 2025

Maximizing Safety, Consistency and Acoustic Output: A Review of Shockwave IVL’s Mechanism of Action

Presenter: James C. Spratt

October 26, 2025

Presentation TCT 2025

TCT 133: Shockwave Balloon or Atherectomy with Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial.

Presenter: Johan R. Bennett

October 26, 2025

Presentation TCT 2025

Shockwave Balloon vs. Atherectomy With Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial

Presenter: Johan R. Bennett

October 25, 2025

Presentation TCT 2025

TCT 1551: A Case Report on the Use of Rotational Atherectomy and Shockwave IVL to Treat Left Main Stent Under-Expansion

Presenter: Zhiyong Zhang

October 25, 2025

Presentation TCT 2025

The Innovator’s Vision: “Cracking the Code” of Calcium Management: Intravascular Lithotripsy (Shockwave)

Presenter: Todd J. Brinton

October 25, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Conference News EuroPCR 2025

IVL Effective in Severely Calcified Lesions, Especially in Women

Yael L. Maxwell

May 22, 2025

CME

Advertisement

First-in-Human Study of a Novel IVL-Based Coronary Crossing Device for Calcified Lesions (Shockwave)

TCT 165: To evaluate the impact of dose dependency on calcium fractures from the shockwave balloon in calcified lesions

You Asked; We Delivered: Introducing Shockwave IVL’s C2 Aero Coronary Catheter - C2+ vs. Aero C2

You Asked; We Delivered: Introducing Shockwave IVL’s C2 Aero Coronary Catheter - C2 Aero "Case in a Box"

Delivering with Clinical Data: Shockwave IVL’s Proven Crack Record

Maximizing Safety, Consistency and Acoustic Output: A Review of Shockwave IVL’s Mechanism of Action

TCT 133: Shockwave Balloon or Atherectomy with Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial.

Shockwave Balloon vs. Atherectomy With Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial

TCT 1551: A Case Report on the Use of Rotational Atherectomy and Shockwave IVL to Treat Left Main Stent Under-Expansion

The Innovator’s Vision: “Cracking the Code” of Calcium Management: Intravascular Lithotripsy (Shockwave)

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

IVL Effective in Severely Calcified Lesions, Especially in Women

The Role of Atrial Shunts in the Treatment of HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content